Tag:
Vaccines
Latest Headlines
Latest Headlines
Merck expands packaging plant to take on more vaccines
With increased production and growing supplies, the company hopes to regain some of the momentum with Zostavax that was lost when production issues derailed plans in 2006.
With upgrades, India to reopen 3 vaccine plants
An Indian company known for making condoms has completed upgrades on a vaccine plant there and is nearing completion on two others.
GSK to invest more than £500 million in new manufacturing in U.K.
GlaxoSmithKline ( $GSK ) has decided to build a £350 million ($463 million) plant in Ulverston, U.K., but to also invest another £230 million ($304 million) at the other three sites the company was considering.
GlaxoSmithKline, Daiichi Sankyo join forces to sell vaccines in Japan
GlaxoSmithKline ( $GSK ) and Daiichi Sankyo ( $D4S.BE ) will jointly invest about $1.2 million and pool their vaccine operations into a 50/50 joint venture that they expect will be largest vaccine company in Japan.
GSK and Daiichi create joint development venture in Japan
GlaxoSmithKline ( $GSK ) and Japan's number three pharma company Daiichi Sankyo have created a joint venture to bring new treatments to the Japanese market.
Pfizer's Emini targets pneumonia market with Prevnar 13
In November, Pfizer ( $PFE ) won expert backing for the use of its vaccine Prevnar 13 to protect adults over 50 from pneumococcal infections. If the FDA agrees with the panel's decision--and it usually
Developer looks to nanoparticles for smoking cessation vaccine
Last week, Selecta Biosciences, a 2011 Fierce 15 company , announced that it has started a Phase I trial of a synthetic nanoparticle vaccine for smoking cessation. The shot, called SEL-068, is
GSK, Alnylam team to speed vaccine production
Evidence of advances to speed up vaccine manufacturing--a wish-list item for governments around the world wanting to establish national disease-protection programs--appeared on two fronts this week.
China to ramp up epidemic vax system
To improve its ability to cope with epidemic emergencies, China says it will spend $1.45 billion to develop a national vaccine provision system. The goal is to create a system that can supply
Nobel winner fought his cancer with own research until death
Dr. Ralph Steinman became the subject of his own pioneering research in the field of immunology after he was diagnosed with pancreatic cancer four and half years ago. After winning a Nobel prize this
